Salinomycin inhibits cholangiocarcinoma growth by inhibition of autophagic flux

INTRODUCTION: Cholangiocarcinoma is characterized by aggressive tumor growth, high recurrence rates, and resistance against common chemotherapeutical regimes. The polyether-antibiotic Salinomycin is a promising drug in cancer therapy because of its ability to overcome apoptosis resistance of cancer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Klose, Johannes, Guerlevik, Engin, Trostel, Tina, Kühnel, Florian, Schmidt, Thomas, Schneider, Martin, Ulrich, Alexis
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790487/
https://ncbi.nlm.nih.gov/pubmed/29423070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23339
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars